MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with E

Estriol

Estriol 30microgram pessaries

No stability information

Stability notes for Estriol 30microgram pessaries

There are no stability notes for this medicine.

Supplier

Imvaggis 0.03mg pessaries (Besins Healthcare (UK) Ltd)

Estriol 500microgram pessaries

No stability information

Stability notes for Estriol 500microgram pessaries

There are no stability notes for this medicine.

Suppliers

Estriol 500microgram pessaries (A A H Pharmaceuticals Ltd)
Estriol 500microgram pessaries (Alliance Healthcare (Distribution) Ltd)
Estriol 500microgram pessaries (Aspen Pharma Trading Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.